跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIVARACETAM SANDOZ 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BRIVARACETAM SANDOZ 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
BRIVARACETAM SANDOZ 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 30, 2025
Approval ID
b5efd163773576de
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
b5efd163773576de
Drug Cima Aemps Name
BRIVARACETAM SANDOZ 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
90414
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2025-06-30
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
BRIVARACETAM
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 30, 2025
Approval ID
b5efd163773576de
Type
Standard
Back to CIMA-AEMPS Approvals